Research and Markets: Contract Research Organizations in Asia 2011 with Comprehensive List of Clinical Research Organizati

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/21bcd5/contract_research) has announced the addition of the "Contract Research Organizations in Asia 2011" report to their offering.

This report on Asian CROs provides a comprehensive list of clinical research organizations throughout Asia. The countries covered include: Japan, Taiwan, Korea, Singapore, Hong Kong, India, China, Malaysia, Philippines, Indonesia, Thailand and Vietnam. Included for each CRO are contact information, description of services and further comments about the organization.

This report includes an overview of the increasing trend of pharmaceutical companies outsourcing clinical research to CROs in Asia, as well as some recommendations for choosing the right Asian CRO. In addition, this report presents short overviews of the regulatory procedures required for obtaining government approval to conduct a clinical trial in each of the above countries.

Updates for 2011 include:

  • An expanded list of 192 CROs in Asia, including China, India, Japan, Korea and South East Asia.
  • There 20 new CROs listed and 13 CROs with updated information.
  • Introductory information on clinical trials in 12 Asian countries

Key Topics Covered:

I. Conducting Clinical Trials In Asia

II. Why Go to Asian CROs?

III. What to Watch Out For

IV. How to Choose a CRO

V. Which Countries?

VI. Japan: Clinical Trials in Japan and listing of CROs

VII. Taiwan: Clinical Trials in Taiwan and listing of CROs

VIII. Singapore: Clinical Trials in Singapore and listing of CROs

IX. Hong Kong: Clinical Trials in Hong Kong and listing of CROs

X. Korea: Clinical Trials in Korea and listing of CROs

XI. India: Clinical Trials in India and listing of CROs

XII. China: Clinical Trials in China and listing of CROs

XIII. Malaysia: Clinical Trials in Malaysia and listing of CROs

XIV. Philippines: Clinical Trials in the Philippines and listing of CROs

XV. Indonesia: Clinical Trials in Indonesia and listing of CROs

XVI. Thailand: Clinical Trials in Thailand and listing of CROs

XVI. Vietnam: Clinical Trials in Vietnam and listing of CROs

For more information visit http://www.researchandmarkets.com/research/21bcd5/contract_research



CONTACT:

Research and Markets
Laura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
[email protected]

KEYWORDS:   Asia Pacific

INDUSTRY KEYWORDS:   Health  Clinical Trials  Research  Science

MEDIA:

Logo
 Logo

Suggested Articles

Bristol-Myers already has one Opdivo combo approved in kidney cancer, but it’s going for another—and new trial data could be just the ticket.

Trodelvy's bladder cancer data look weaker compared with what Seattle Genetics' rival drug Padcev achieved in its own trial.

Merck’s Keytruda is battling Bristol Myers' Opdivo in adjuvant melanoma, and it just racked up trial results that will help it even the playing field.